ArticleToxics2026
A Novel Cerium-Loaded Amyloid Hybrid Membrane for Advanced Removal of Fluorine-18 in Medical Wastewater.
Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Despite its critical role in disease diagnosis as a radiopharmaceutical, Fluorine-18 generates medical wastewater that necessitates efficient treatment, for which membrane adsorption stands out as a potent method, albeit one that demands high-performance membranes with exceptional permeability and adsorption capacity. This study presents a novel cerium-loaded amyloid fibril hybrid membrane designed for efficient removal of fluorine-18 from such wastewater. The membrane is fabricated through a facile process involving oxidation-precipitation of cerium species onto amyloid fibrils, followed by vacuum filtration, with further compositional tuning via incorporation of porous silica or activated carbon dopants. The resulting membrane retains the characteristic amyloid fibril structure and exhibits high water permeability with a flux of up to 803.3 L/(m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.